Teaching an old dog new tricks: The case of Fenbendazole.

The objective of this study is the assessment of the cytotoxic effect of fenbendazole and its commercially available formulation, which is used for its antihelmintic properties. The formulation was tested for its efficacy as well as the determination of the ingredients with proliferation assays and analytical techniques. HPLC, LC-MS and NMR confirmed the stated amount of active ingredient on the label.

Genistein as a dietary supplement; formulation, analysis and pharmacokinetics study.

The objective of this study is to improve and optimize the formulation of Genistein in capsules in order to result in a better pharmacokinetic profile comparing to existing commercial products. In order to do this, five different formulations of Genistein capsules were developed and examined by reviewing their disintegration and dissolution properties. Furthermore, flowability of the powder along with potent incompatibilities between Genistein and its excipients were monitored through their thermal properties.

Evaluation of Tegaran Formula ZhenHua cytotoxicity against human cancer cell lines.

The aim of this study is to evaluate the potential health effects of Tegaran Formula ZhenHua, a nutritional supplement used mainly by cancer patients. Its active ingredients and cytotoxicity was assessed with analytical methods and viability assays, respectively. The analytical methods consisted of dissolution, disintegration, HPLC, LC/MS, GC/MS and NMR.

The re-introduction of ischemic preconditioning is able to protect myocardium after repeated long reperfusion intervals.

Classic ischemic preconditioning confers protection to the vulnerable myocardium following brief periods of ischemia with short intermittent periods of reperfusion. The aims of this study were: (i) to ascertain the protection from preconditioning using a relatively long reperfusion interval; (ii) to see whether this protection exists if preconditioning and long reperfusion is repeated and (iii) to evaluate the effect that an additional preconditioning stimulus has if it is given immediately before the sustained ischemia. Following anesthesia, in-vivo hearts were preconditioned with a 5 minute coronary ligation followed by 10 minutes reperfusion (Group A).